TG Therapeutics, Inc. (TGTX) Social Stream
TG THERAPEUTICS INC (TGTX) Price Targets From Analysts
Use the tables below to see what analysts covering TG THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 6 | $84 | $54 | $65 | $10.14 | 541.03% |
| 2021-11-10 | 6 | $84 | $54 | $64.333 | $10.14 | 534.45% |
| 2021-12-13 | 7 | $75 | $36 | $53.714 | $10.14 | 429.72% |
| 2022-01-24 | 7 | $70 | $36 | $53 | $10.14 | 422.68% |
| 2022-01-28 | 7 | $68 | $36 | $52.714 | $10.14 | 419.86% |
| 2022-02-15 | 6 | $68 | $36 | $50.285 | $10.14 | 395.91% |
| 2022-02-25 | 6 | $68 | $35 | $48.285 | $10.14 | 376.18% |
| 2022-03-02 | 7 | $68 | $35 | $48.285 | $10.14 | 376.18% |
| 2022-04-01 | 7 | $68 | $35 | $44.857 | $10.14 | 342.38% |
| 2022-04-18 | 7 | $47 | $19 | $37.857 | $10.14 | 273.34% |
| 2022-05-12 | 7 | $40.001 | $19 | $25.285 | $10.14 | 149.36% |
| 2022-06-03 | 8 | $40.001 | $5 | $22.75 | $10.14 | 124.36% |
| 2022-09-17 | 7 | $40.001 | $5 | $22 | $10.14 | 116.96% |
| 2022-11-11 | 8 | $40.001 | $5 | $22 | $10.14 | 116.96% |
| 2022-11-14 | 7 | $40.001 | $5 | $20.428 | $10.14 | 101.46% |
| 2022-12-29 | 9 | $40.001 | $6 | $20 | $10.14 | 97.24% |
| 2022-12-30 | 9 | $40.001 | $5 | $19.555 | $10.14 | 92.85% |
| 2023-01-03 | 9 | $40.001 | $5 | $20 | $10.14 | 97.24% |
| 2023-01-24 | 9 | $40.001 | $5 | $21.444 | $10.14 | 111.48% |
| 2023-01-26 | 9 | $26 | $6 | $19.111 | $10.14 | 88.47% |
| 2023-03-01 | 9 | $26 | $6 | $19.777 | $10.14 | 95.04% |
| 2023-04-10 | 9 | $28 | $6 | $20.777 | $10.14 | 104.9% |
| 2023-04-12 | 9 | $39 | $6 | $22.555 | $10.14 | 122.44% |
| 2023-04-17 | 9 | $39 | $6 | $23 | $10.14 | 126.82% |
| 2023-05-01 | 8 | $39 | $6 | $23.222 | $10.14 | 129.01% |
| 2023-05-02 | 8 | $42 | $6 | $24.888 | $10.14 | 145.44% |
| 2023-06-09 | 8 | $42 | $6 | $28.388 | $10.14 | 179.96% |
| 2023-06-26 | 8 | $42 | $6 | $28.944 | $10.14 | 185.44% |
| 2023-08-01 | 8 | $42 | $6 | $30.055 | $10.14 | 196.4% |
| 2023-08-02 | 8 | $42 | $6 | $29.611 | $10.14 | 192.02% |
| 2023-09-08 | 8 | $41 | $6 | $27.277 | $10.14 | 169% |
The Trend in the Analyst Price Target
TGTX's average price target has moved down $11.22 over the prior 40 months.
TGTX reports an average of 77.81% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-14 | 8 | 40.001 | 5 | 19.250 | 8.71 | 121.01% |
| 2023-03-02 | 9 | 28.000 | 6 | 20.777 | 15.87 | 30.92% |
| 2023-04-12 | 9 | 39.000 | 6 | 22.555 | 20.07 | 12.38% |
| 2023-04-21 | 8 | 39.000 | 6 | 23.222 | 22.15 | 4.84% |
| 2023-07-24 | 8 | 42.000 | 6 | 30.055 | 20.28 | 48.2% |
TGTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.63 | 6 | 0 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
TGTX's average broker recommendation rating worsened by 0.62 over the prior 38 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- TGTX has a lower variance in analysts' estimates than -3914.05% of all US stocks.
- TGTX has a greater upside potential (average analyst target price relative to current price) than 3842.83% of all US stocks.
- TGTX has a greater average analyst price target than 1928.95% of stocks in the mid market cap category.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, TG THERAPEUTICS INC's number of analysts covering the stock is higher than 2379.87% of them.
Stocks similar to TG THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OPK, MNKD, and AMRN.
View All Top Stocks by Price Target
Is TGTX a Buy, Hold or Sell? See the POWR Ratings now!